10X Genomics

About

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

Pleasanton,California,United States
251 - 500
http://10xgenomics.com

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $75M
Industries: Biotechnology,Genetics,Health Care,Medical
Founded date: Jan 1, 2012
Number Of Employee: 251 - 500
Operating Status: Active
Stock Symbol: nasdaq:TXG
Legal Name: 10X Genomics, Inc.

10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$632.60M

10X Genomics has raised a total of $632.60M in funding over 2 rounds. Their latest funding was raised on Sep 11, 2019 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 11, 2019	IPO	$390M	—	—	—	Detail
Jan 7, 2019	Series D	$35M	3	Meritech Capital Partners	—	Detail
Apr 26, 2018	Series D	$50M	5	Meritech Capital Partners	—	Detail
Feb 17, 2016	Series C	$75M	5	Fidelity Management and Research Company	—	Detail
Dec 12, 2014	Series B	$55.50M	3	Foresite Capital	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

10

10X Genomics is funded by 10 investors. Meritech Capital Partners and Fidelity Management and Research Company are the most recent investors.

Investor Name	Lead Investor	Funding Round
Meritech Capital Partners	Yes	Series D
Fidelity Management and Research Company	Yes	Series C
Silicon Valley Bank	Yes	Seed
Fidelity	—	Series D
Wells Fargo & Company	—	Series D
Paladin Capital Group	—	Series D
SoftBank Vision Fund	—	Series D
Wells Fargo Strategic Capital	—	Series D
Foresite Capital	—	Series C
Venrock	—	Series C

Employee Profiles

Number of Employee Profiles

22

10X Genomics has 22 current employee profiles, including Executive Jonathan Schimmel

Executive

Executive

Employee

Executive

Executive

Acquisition

10X Genomics has acquired 5 organizations. Their most recent acquisition was EPINOMICS on Aug 28, 2018. They acquired EPINOMICS for 0.

Date Company Name	Industry	Acquisition Type	Price
Aug 28, 2018 EPINOMICS	Analytics	acquisition	—	Detail
Dec 10, 2018 Spatial Transcriptomics	Biotechnology	acquisition	—	Detail
Sep 21, 2020 CARTANA	Biotechnology	acquisition	€ 42.50M	Detail
Oct 5, 2020 ReadCoor	Biotechnology	acquisition	$ 350M	Detail
Feb 25, 2021 Tetramer Shop	Biotechnology	acquisition	—	Detail